SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001171843-14-001683
Filing Date
2014-04-14
Accepted
2014-04-14 17:00:43
Documents
4
Period of Report
2013-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A (AMENDMENT NO. 1) f20fa_040314.htm 20-F/A 82071
2 EXHIBIT 4.64 exh_464.htm EX-4.64 273587
3 EXHIBIT 12.1 exh_121.htm EX-12.1 5050
4 EXHIBIT 12.1 exh_122.htm EX-12.2 5336
  Complete submission text file 0001171843-14-001683.txt   367150
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 20-F/A | Act: 34 | File No.: 000-53805 | Film No.: 14763047
SIC: 2834 Pharmaceutical Preparations